https://www.selleckchem.com/pr....oducts/2,4-thiazolid
Liver transplantation (LT) is the only available curative treatment for patients with end-stage liver disease. Early allograft dysfunction (EAD) is a life-threatening complication of LT and is thought to be mediated in large part through ischemia-reperfusion injury (IRI). However, the underlying mechanisms linking IRI and EAD after LT are poorly understood. Most previous studies focused on the clinical features of EAD, but basic research on underlying mechanisms is insufficient, due in part to a lack of suitable animal mod
Like
Comment
Share
